Hotline:+86 2884841969
Outbound Sales&Marketing
 
Cynthia 
Tel: +86 2884841969 
Mobile: +86 17390183901 (English) 
Skype/Wechat:+86 18716376478
 
Mr. Yang  
Tel: +86 2884871826
Mobile: +86 13908183771   
Email: yangcx@enlaibio.com
 
Amy Yang
Tel:+86-28-84841969
Mobile:+8618980839296
QQ:551604319
Skype/Wechat:+86 18280195889
Email:551604319@qq.com
Enlai News Your current location: Homepage >Enlai News
请添加图片
First line treatment for chronic lymphocytic leukemia

As a first line treatment drugs for chronic lymphocytic leukemia, Ibrutinib improves survival compared with Ofatumumab in patients with previously treated Chronic Lymphocytic Leukemia.

Can you manufacture other peptides exclusively from your product list?2019-05-17

From Poverty to Harvard Postdoc2013-10-24

What are the acceptable payment methods?2019-05-05

Fingerprints Expose Chemical Identities 2019-01-04

2019 CPHI Shanghai Bio-Pharm Expo 2019-08-18